Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMYRIS, INC.AMRS · Entity 91367 | Interim CFO | June 03, 2019 | June 13, 2019 |
| SOLENO THERAPEUTICS INCSLNO · Entity 46432 | Chief Financial Officer | January 24, 2019 | January 29, 2019 |
| SmartRent, Inc.SMRT · Entity 6112 | Chief Financial Officer | November 29, 2021 | November 30, 2021 |
| Vera Therapeutics, Inc.VERA · Entity 4358 | Chief Financial Officer | May 13, 2021 | May 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMYRIS, INC.
Report date June 03, 2019 · Filed June 13, 2019
This filing explicitly reported no securities owned.
SOLENO THERAPEUTICS INC
Report date January 24, 2019 · Filed January 29, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2029-01-24 | Direct | 10,000 |
Reported balance
After 2019-01-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-24 · Grant · Acquired 10,000 · Balance 10,000 F1: One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of January 24, 2019 (the "Vesting Commencement Date") and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of January 24, 2019 (the "Vesting Commencement Date") and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date.
SmartRent, Inc.
Report date November 29, 2021 · Filed November 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 5,100 |
Ending reported balance
After 2021-11-29 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-11-29 · Purchase · Acquired 4,000 · Balance 4,000 Row 2 · 2021-11-29 · Purchase · Acquired 199 · Balance 4,199 Row 3 · 2021-11-29 · Purchase · Acquired 901 · Balance 5,100 |
Vera Therapeutics, Inc.
Report date May 13, 2021 · Filed May 13, 2021
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2021 Filed Nov 30, 2021 13:30 UTC | SmartRent, Inc. SMRT · Entity 6112 | PurchaseClass A Common Stock | 901 | $9.64 | $8,685.64 |
DisclosureSEC source: 0001209191-21-067097 · doc4.xml · nonDerivative · entry 3 Wolter Jonathan · CIK 0001744216 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 13:30 UTC | SmartRent, Inc. SMRT · Entity 6112 | PurchaseClass A Common Stock | 199 | $9.61 | $1,912.39 |
DisclosureSEC source: 0001209191-21-067097 · doc4.xml · nonDerivative · entry 2 Wolter Jonathan · CIK 0001744216 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,199 Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 13:30 UTC | SmartRent, Inc. SMRT · Entity 6112 | PurchaseClass A Common Stock | 4,000 | $9.60 | $38,400.00 |
DisclosureSEC source: 0001209191-21-067097 · doc4.xml · nonDerivative · entry 1 Wolter Jonathan · CIK 0001744216 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| January 24, 2019 Filed Jan 29, 2019 01:11 UTC | SOLENO THERAPEUTICS INC SLNO · Entity 46432 | GrantEmployee stock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0000899243-19-002086 · doc4.xml · derivative · entry 1 Wolter Jonathan · CIK 0001744216 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-01-24 F1 · derivative.exercise_date: One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of January 24, 2019 (the "Vesting Commencement Date") and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date. Read SEC document |
| June 15, 2018 Filed Jun 20, 2018 22:07 UTC | SOLENO THERAPEUTICS INC SLNO · Entity 46432 | GrantEmployee stock option (right to buy) · Derivative | 24,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0000899243-18-017432 · doc4.xml · derivative · entry 1 Wolter Jonathan · CIK 0001744216 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2028-06-15 F1 · derivative.exercise_date: Twenty-five percent (25%) of the Shares subject to the Option shall vest three (3) months after the Vesting Commencement Date (June 1, 2018), and one-third (1/3) of the Shares subject to the Option shall vest every three months thereafter on the same day of the month as the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.